BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed pharmaceutical products, today announced that Mr. Steven B. Ratoff, NovaDel’s Chairman, President and Chief Executive Officer, will be presenting at the ROTH 23rd Annual OC Growth Stock Conference.
